Fig. 3From: Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signalingGenetic alterations of KPNA2 in ovarian cancer subgroups. Subgroup analysis of multiple clinic pathologic features of ovarian cancer samples in the TCGA. (a) rases; (b) ages; (c) stages; (d) TP53-MutantBack to article page